Suppr超能文献

[奥昔苯酮对离体大鼠心脏骤停-再灌注损伤的保护作用]

[Protection of oxyphenamone against cardiac arrest-reperfusion injury of isolated rat hearts].

作者信息

Fan Li-li, Li Hua, Fan Ming-jie, Zhang Run-dong

机构信息

Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

出版信息

Yao Xue Xue Bao. 2005 Aug;40(8):705-10.

Abstract

AIM

To ascertain the protective effect of oxyphenamone, a novel inodilator, against myocardial ischemia-reperfusion injury.

METHODS

A model of global myocardial ischemia-reperfusion injury (I-R) was established by arresting the infusion to heart 40 min followed by reperfusion 30 min in the preparations of rat Langendorff' s hearts. The protective effects of oxyphenamone were evaluated by the cardiac function, the activity of creatine phosphokinase (CPK) in coronary efflux, the myocardial energy metabolism and antioxidation, the membrane fluidity, the activity of ATPase, the calcium content and ultrastructure of mitochondria.

RESULTS

Administration of oxyphenamone to the infused heart before cardiac arrest and during reperfusion ameliorated the decreases of myocardial contractile force and coronary flow and the increase of the activity of CPK in coronary efflux induced by cardiac arrest-reperfusion (A-R). At the concentration of 1-10 micromol x L(-1) oxyphenamone dose-dependently antagonized the decrease of myocardial adenosine triphosphate (ATP) and creatine phosphate (PCr) induced by A-R, increased the activities of myocardial superoxide dismutase (SOD) and glutathione peroxidase (GSH-px), decreased mitochondrial malondialdehyde (MDA) content and increased membrane fluidity, glutathione (GSH) content and the activities of GSH-px and ATPase of mitochondria. The parameters mentioned above even maintained at normal level when high concentration of oxyphenamone (10 micromol x L(-1)) was applied. Oxyphenamone also antagonized the mitochondrial calcium overload and the ultrastructure damage of mitochondria induced by A-R obviously. Addition of oxyphenamone (1-100 micromol x L(-1)) to the system of Fe2+-cysteine or Fe2+-H2O2, which could produce oxygen free radicals, decreased MDA content and increased GSH and membrane fluidity of mitochondria significantly.

CONCLUSION

With the results of examinations of the cardiac physiological function, myocardial energy metabolism and antioxidation and the calcium content and ultrastructure of mitochondria, it is indicated that oxyphenamone could protect the isolated rat heart against cardiac arrest-reperfusion injury markedly and the mechanism of its action may be related to the antioxidative effect of this agent.

摘要

目的

确定新型正性肌力扩血管药奥昔苯宁对心肌缺血再灌注损伤的保护作用。

方法

在大鼠Langendorff心脏标本中,通过停止灌注心脏40分钟,随后再灌注30分钟,建立全心缺血再灌注损伤(I-R)模型。通过心脏功能、冠状动脉流出液中肌酸磷酸激酶(CPK)活性、心肌能量代谢与抗氧化作用、膜流动性、ATP酶活性、钙含量以及线粒体超微结构来评估奥昔苯宁的保护作用。

结果

在心脏停搏前及再灌注期间给灌注心脏应用奥昔苯宁,可改善心脏停搏-再灌注(A-R)所致的心肌收缩力和冠状动脉血流量降低以及冠状动脉流出液中CPK活性升高。在1-10微摩尔×L⁻¹浓度下,奥昔苯宁剂量依赖性地拮抗A-R所致的心肌三磷酸腺苷(ATP)和磷酸肌酸(PCr)降低,增加心肌超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-px)活性,降低线粒体丙二醛(MDA)含量,增加膜流动性、谷胱甘肽(GSH)含量以及线粒体GSH-px和ATP酶活性。当应用高浓度奥昔苯宁(10微摩尔×L⁻¹)时,上述参数甚至维持在正常水平。奥昔苯宁还明显拮抗A-R所致的线粒体钙超载和线粒体超微结构损伤。向可产生氧自由基的Fe²⁺-半胱氨酸或Fe²⁺-H₂O₂体系中加入奥昔苯宁(1-100微摩尔×L⁻¹),可显著降低MDA含量,增加线粒体GSH和膜流动性。

结论

通过对心脏生理功能、心肌能量代谢与抗氧化作用以及线粒体钙含量和超微结构的检测结果表明,奥昔苯宁可显著保护离体大鼠心脏免受心脏停搏-再灌注损伤,其作用机制可能与其抗氧化作用有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验